Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study. Samara E, Winkle P, Pardo P, Henney HR, Way SL, Brown E, Lee A, Blight AR J Clin Pharmacol. 2013 Sep 30. PMID: 24150835. Abstract CommentRecommendBookmarkWatch